Cited by 178Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery

Chamberlain, Samuel R., Robbins, Trevor W., Winder-Rhodes, Sophie, Müller, Ulrich, Sahakian, Barbara J., Blackwell, Andrew D., Barnett, Jennifer H.·2011·Biological Psychiatry

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent condition associated with cognitive dysfunction. The Cambridge Neuropsychological Test Automated Battery is a computerized set of tests that has been widely used in ADHD and in translation/back-translation. Following a survey of translational research relevant to ADHD in experimental animals, a comprehensive literature review was conducted of studies that had used core Cambridge Neuropsychological Test Automated Battery tests 1) to evaluate cognitive dysfunction in ADHD and 2) to evaluate effects of salient drugs in patients and in volunteers. Meta-analysis was conducted where four or more independent datasets were available. Meta-analysis revealed medium-large decrements in ADHD for response inhibition (d = .790, p < .001), working memory (d = .883, p < .001), executive planning (d = .491, p < .001), and a small decrement in attentional set shifting (d = .160, p = .040). Qualitative review of the literature showed some consistent patterns. In ADHD, methylphenidate improved working memory, modafinil improved planning, and methylphenidate, modafinil, and atomoxetine improved inhibition. Meta-analysis of modafinil healthy volunteer studies showed no effects on sustained attention or set shifting. Results were paralleled by findings in experimental animals on comparable tests, enabling further analysis of drug mechanisms. Substantial cognitive deficits are present in ADHD, which can be remediated somewhat with curren…

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2010.08.019

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • All medications currently approved for the treatment of ADHD influence norepinephrine transmission, and all can improve at least some aspects of PFC function.

    “All medications currently approved for the treatment of ADHD influence NE transmission (Figure 2E), and all can improve at least some aspects of PFC function (82).”
  • All current pharmacological treatments for ADHD facilitate catecholamine transmission.

    “All current pharmacological treatments for ADHD facilitate catecholamine transmission, and basic research suggests that these compounds have prominent actions in the prefrontal cortex (PFC).”
  • These compounds have prominent actions in the prefrontal cortex.

    “All current pharmacological treatments for ADHD facilitate catecholamine transmission, and basic research suggests that these compounds have prominent actions in the prefrontal cortex (PFC).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chamberlain, S. R., Robbins, T. W., Winder-Rhodes, S., Müller, U., Sahakian, B. J., Blackwell, A. D., & Barnett, J. H.
Affiliations
University of Cambridge (GB)
Corresponding author
Chamberlain, Samuel R.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2011-06
Volume
69
Issue
12
Pages
1192-1203
ISSN
0006-3223 (ISSN-L)
OpenAlex
W1978525999
Cited by
178
References
32
Citations by year
2026: 6 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 14 · 2020: 8 · 2019: 9 · 2018: 18 · 2017: 16 · 2016: 16 · 2015: 8 · 2014: 19 · 2013: 17 · 2012: 21
FWCI
2.29
Type
journal article
Language
en
Open access
closed
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
Funders
  • Wellcome Trust
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
attention deficit hyperactivity disorder, CANTAB, frontostriatal dysfunction, cognitive impairment, response inhibition, working memory, executive planning, set-shifting, methylphenidate, modafinil, atomoxetine, ADHD medication, animal model of ADHD, sustained attention
MeSH terms
Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Cognition, Cognition Disorders, Corpus Striatum, Frontal Lobe, Humans, Neural Pathways, Neuropsychological Tests, Psychomotor Performance, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review